Frank Adell

Title: Chief Executive Officer
Company: Cognos Therapeutics Inc.
Location: Marina Del Rey, California, United States

Frank Adell, chief executive officer at Cognos Therapeutics Inc., has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in technology and medical devices.

With nearly four and a half decades of experience to his credit, Mr. Adell has built a distinguished career in technology and medical devices. He currently excels as the chief executive officer of Cognos Therapeutics Inc., a role he has held since its inception. Cognos Therapeutics is a pioneering medical device company advancing AI-driven, implantable pumps for precise drug delivery, with a focus on neurological and oncological conditions. Their flagship product, the SINNAIS™ smart pump, integrates AI, blockchain, and cloud connectivity to deliver treatments directly to the brain, overcoming the blood-brain barrier to improve outcomes for central nervous system diseases and certain cancers. 

Mr. Adell’s previous experience includes serving as co-founder and former chief executive officer of Autonomous Medical Devices Incorporated from 2016 to 2021, co-founder, board member, and executive vice president at Magnetecs from 2000 to 2015, and president and chief executive officer of Pharmaco-Kinesis Corp from 2006 to 2015. Pharmaco-Kinesis developed a smart implanted pump for drug delivery, which led to its eventual acquisition by Cognos Therapeutics in 2015. Additionally, he was chief executive officer of Newzaust Inc. from 1990 to 2000, founder of the Australian and New Zealand Marketing Company from 1985 to 1990, and held roles with Bechtel Corporation from 1980 to 1985.

Mr. Adell takes pride in building early-stage companies by establishing robust organizational structures to attract seed investments and secure funding for growth. He excels at recruiting top executive talent and assembling skilled technical teams with expertise in targeted industries. His ability to form strategic partnerships with well-capitalized companies has earned him recognition, often leading to successful collaborations and commercial exits. He holds 50 patents, including 33 pump patents granted by the U.S. government and internationally, and his achievements include being recognized by Fortune 500 Magazine for social media initiatives, receiving the Congressional Medal of Distinction from President George W. Bush at the President’s Dinner in 2008, the Congressional Order of Merit in 2007, and a Letter of Recognition for Technology from the White House and the Federal Aviation Administration.

Reflecting on his path, Mr. Adell laid a solid educational foundation, earning a Bachelor of Science in Nuclear Engineering from the University of Washington in 1980. He chose his profession to make a positive impact on people’s lives, and he takes the most pride in the development of the smart implanted pump, which has the potential to greatly improve the lives of many patients. He attributes his success to his passion for his work and is hopeful that the smart pump will soon be ready to assist cancer patients and those with Alzheimer’s disease. Driven by a desire to leave the world in a better state, he aspires to save lives and create a lasting legacy. In advising aspiring professionals, he emphasizes the importance of perseverance, passion, and having the drive to pursue one’s goals, believing that individuals can achieve more than they initially dream.

For more information, please visit:

LinkedIn 

Cognos Therapeutics

Contact Mr. Adell:

Share with:

Facebook
Twitter
LinkedIn

More to explore

Daniel Lee, BA

Title: Cyber Risk Associate and Vice President Company: MUFG Bank Ltd. Location: Charlotte, North Carolina, United States Daniel Lee, BA, cyber

Per (Pär) Edin

Title: Board Director and Advisory Partner Company: KPMG Location: Los Altos, California, United States Per (Pär) Edin, board director and advisory

Archives
Categories